GT BIOPHARMA INC's ticker is and the CUSIP is 36254L959. A total of 1 filers reported holding GT BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
This page lists GT BIOPHARMA INC's shareholders in Q3 2023. To view GT BIOPHARMA INC's shareholder history, click here.